F G M Smeets1,2, A A M Masclee1,2, D Keszthelyi1,2, E T T L Tjwa3, J M Conchillo1,2. 1. Division of Gastroenterology and Hepatology, Maastricht University Medical Center, Maastricht, The Netherlands. 2. NUTRIM, School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, The Netherlands. 3. Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, The Netherlands.
Abstract
BACKGROUND: Achalasia is characterized by a functional esophagogastric junction (EGJ) obstruction. The functional luminal imaging probe (EndoFLIP) is a method to assess EGJ distensibility. In a homogeneous group of newly diagnosed achalasia patients treated with pneumatic dilation (PD), we aimed (i) to determine whether the assessment of EGJ distensibility has added value in the management of achalasia patients and (ii) to evaluate whether EGJ distensibility differs between achalasia subtypes. METHODS: Twenty-six newly diagnosed achalasia patients were treated by graded PD (30 and 35 mm) separated by 1 week. EGJ distensibility was measured with the EndoFLIP technique before and after 30 mm PD. Good clinical outcome was defined as an Eckardt score <4 at 1-year follow-up. Fifteen healthy controls underwent an EndoFLIP measurement as control group. KEY RESULTS: Newly diagnosed achalasia patients had reduced EGJ distensibility compared to healthy controls (0.9 [0.7-1.5] vs 3.4 [2.7-4.2] mm(2) /mmHg, p < 0.01), and EGJ distensibility was lower in type II compared to type I patients (0.8 [0.7-1.1] vs 1.5 [0.9-1.9] mm(2) /mmHg, p = 0.02). EGJ distensibility was increased after PD from 0.9 (0.7-1.5) to 4.2 (3.0-5.7) mm(2) /mmHg (p < 0.001). No difference was found in EGJ distensibility directly after PD between patients with good and poor clinical outcome at 1-year follow-up. CONCLUSIONS & INFERENCES: Assessment of EGJ distensibility with the EndoFLIP technique is able to demonstrate the functional EGJ obstruction in newly diagnosed achalasia patients and EGJ distensibility differs between achalasia subtypes. Although PD improves EGJ distensibility, assessment of EGJ distensibility with a limited number of distension steps provides no additional information that is useful for clinical evaluation and management of achalasia patients.
BACKGROUND:Achalasia is characterized by a functional esophagogastric junction (EGJ) obstruction. The functional luminal imaging probe (EndoFLIP) is a method to assess EGJ distensibility. In a homogeneous group of newly diagnosed achalasiapatients treated with pneumatic dilation (PD), we aimed (i) to determine whether the assessment of EGJ distensibility has added value in the management of achalasiapatients and (ii) to evaluate whether EGJ distensibility differs between achalasia subtypes. METHODS: Twenty-six newly diagnosed achalasiapatients were treated by graded PD (30 and 35 mm) separated by 1 week. EGJ distensibility was measured with the EndoFLIP technique before and after 30 mm PD. Good clinical outcome was defined as an Eckardt score <4 at 1-year follow-up. Fifteen healthy controls underwent an EndoFLIP measurement as control group. KEY RESULTS: Newly diagnosed achalasiapatients had reduced EGJ distensibility compared to healthy controls (0.9 [0.7-1.5] vs 3.4 [2.7-4.2] mm(2) /mmHg, p < 0.01), and EGJ distensibility was lower in type II compared to type I patients (0.8 [0.7-1.1] vs 1.5 [0.9-1.9] mm(2) /mmHg, p = 0.02). EGJ distensibility was increased after PD from 0.9 (0.7-1.5) to 4.2 (3.0-5.7) mm(2) /mmHg (p < 0.001). No difference was found in EGJ distensibility directly after PD between patients with good and poor clinical outcome at 1-year follow-up. CONCLUSIONS & INFERENCES: Assessment of EGJ distensibility with the EndoFLIP technique is able to demonstrate the functional EGJ obstruction in newly diagnosed achalasiapatients and EGJ distensibility differs between achalasia subtypes. Although PD improves EGJ distensibility, assessment of EGJ distensibility with a limited number of distension steps provides no additional information that is useful for clinical evaluation and management of achalasiapatients.
Authors: Anand S Jain; Dustin A Carlson; Joseph Triggs; Michael Tye; Wenjun Kou; Ryan Campagna; Eric Hungness; Donald Kim; Peter J Kahrilas; John E Pandolfino Journal: Am J Gastroenterol Date: 2019-09 Impact factor: 10.864
Authors: Dustin A Carlson; Peter J Kahrilas; Zhiyue Lin; Ikuo Hirano; Nirmala Gonsalves; Zoe Listernick; Katherine Ritter; Michael Tye; Fraukje A Ponds; Ian Wong; John E Pandolfino Journal: Am J Gastroenterol Date: 2016-10-11 Impact factor: 10.864
Authors: Katharine P Rooney; Alexandra J Baumann; Erica Donnan; Wenjun Kou; Joseph R Triggs; Jacqueline Prescott; Alex Decorrevont; Emily Dorian; Peter J Kahrilas; John E Pandolfino; Dustin A Carlson Journal: Clin Gastroenterol Hepatol Date: 2020-04-11 Impact factor: 11.382
Authors: Amy L Holmstrom; Ryan J Campagna; Dustin A Carlson; John E Pandolfino; Nathaniel J Soper; Eric S Hungness; Ezra N Teitelbaum Journal: Gastrointest Endosc Date: 2021-03-01 Impact factor: 10.396
Authors: Edoardo Savarino; Massimiliano di Pietro; Albert J Bredenoord; Dustin A Carlson; John O Clarke; Abraham Khan; Marcelo F Vela; Rena Yadlapati; Daniel Pohl; John E Pandolfino; Sabine Roman; C Prakash Gyawali Journal: Am J Gastroenterol Date: 2020-11 Impact factor: 12.045